DiNuzzo Private Wealth
CYTK icon

DiNuzzo Private Wealth’s Cytokinetics CYTK Stock Holding History

DiNuzzo Private Wealth’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$528 Buy
8
+4
+100% +$305 ﹤0.01% 1084
2026
Q2 		$341 Buy
4
+3
+300% +$215 ﹤0.01% 1183
2026
Q1 		$66 Buy
+1
New +$64 ﹤0.01% 1298
2024
Q4 		– Sell
-15
Closed -$792 – 1425
2024
Q3 		$792 Buy
15
+7
+88% +$390 ﹤0.01% 950
2024
Q2 		$434 Buy
+8
New +$483 ﹤0.01% 1084

Other funds holding CYTK

Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
E. Ohman J:or Asset Management
E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Yousif Capital Management
Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

DiNuzzo Private Wealth's CYTK Position: Q3 2026 in Review

DiNuzzo Private Wealth increased its Cytokinetics (CYTK) stake by 100% in Q3 2026, buying an estimated $305 and bringing the position to 8 shares worth $528. The position accounts for ﹤0.01% of the portfolio, ranked #1084.

DiNuzzo Private Wealth first reported a position in CYTK in Q2 2024 and has held it in 5 quarters since. The position peaked at $792 in Q3 2024. 91 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • DiNuzzo Private Wealth held 8 shares of Cytokinetics worth $528 as of Q3 2026.
  • DiNuzzo Private Wealth bought 4 Cytokinetics shares in Q3 2026, an estimated $305.
  • Cytokinetics made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q3 2026, its #1084 holding.
  • DiNuzzo Private Wealth first reported a position in Cytokinetics in Q2 2024 and has held it in 5 quarters since.
  • DiNuzzo Private Wealth's Cytokinetics position peaked at $792 in Q3 2024.
  • 91 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.